Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.

[1]  L. Liotta,et al.  Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.

[2]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[3]  J. Meinkoth,et al.  Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation , 2004, Cancer Research.

[4]  M. Clynes,et al.  A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin , 2004, British Journal of Cancer.

[5]  J. Lutz,et al.  Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats. , 2004, Kidney international.

[6]  S. Loitsch,et al.  Modulation of angiogenesis-related protein synthesis by valproic acid. , 2004, Biochemical and biophysical research communications.

[7]  Z. Marinova,et al.  Valproic acid induces functional heat‐shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation , 2009, Journal of neurochemistry.

[8]  L. Boros,et al.  Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice , 2009, Metabolomics.

[9]  J. Gisbert,et al.  Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy , 2010, Gut.

[10]  C. Hetz,et al.  HSP72 Protects Cells from ER Stress-induced Apoptosis via Enhancement of IRE1α-XBP1 Signaling through a Physical Interaction , 2010, PLoS biology.

[11]  S. Burdett,et al.  Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? , 2011, British Journal of Cancer.

[12]  M. Suematsu,et al.  Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells. , 2011, Biochemical and biophysical research communications.

[13]  J. Kwon,et al.  Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  Jeffrey R. Wang,et al.  Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen , 2012, International journal of oncology.

[15]  Y. Jang,et al.  Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. , 2012, Biochemical and biophysical research communications.

[16]  A. Sidana,et al.  Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic Acid , 2012, Journal of biomedicine & biotechnology.

[17]  Cynthia A. Reinhart-King,et al.  Inducing Apoptosis in Rolling Cancer Cells: A Combined Therapy with Aspirin and Immobilized TRAIL and E-Selectin , 2012, Molecular pharmaceutics.

[18]  J. Taub,et al.  Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells , 2012, Pediatric blood & cancer.

[19]  Jie Xiao,et al.  Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells , 2012, Leukemia & lymphoma.

[20]  S. Safe,et al.  Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors , 2012, PloS one.

[21]  Molly Y. Mollica,et al.  Effects of nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NONO-NSAIDs) on melanoma cell adhesion. , 2012, Toxicology and applied pharmacology.

[22]  Stacey A. Kenfield,et al.  Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort , 2012, Cancer Prevention Research.

[23]  Richard O Hynes,et al.  The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. , 2012, Cancer discovery.

[24]  Sukhmahendra Singh,et al.  Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules , 2012, Molecular and Cellular Biochemistry.

[25]  A. Barsegian,et al.  Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. , 2012, Biochemical pharmacology.

[26]  A. Seifalian,et al.  Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells , 2012, World Journal of Surgical Oncology.

[27]  Z. Fishelson,et al.  Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer , 2013, International journal of cancer.